These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2971033)

  • 1. 14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human.
    Adachi T; Morimoto S; Kondoh H; Nagate T; Watanabe Y; Sota K
    J Antibiot (Tokyo); 1988 Jul; 41(7):966-75. PubMed ID: 2971033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial transformation of 6-O-methylerythromycin derivatives.
    Sasaki J; Mizoue K; Morimoto S; Adachi T; Omura S
    J Antibiot (Tokyo); 1988 Jul; 41(7):908-15. PubMed ID: 2971032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylation and N-demethylation of clarithromycin (6-O-methylerythromycin A) by Mucor circinelloides.
    Adachi T; Sasaki J; Omura S
    J Antibiot (Tokyo); 1989 Sep; 42(9):1433-7. PubMed ID: 2529234
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.
    Morimoto S; Nagate T; Sugita K; Ono T; Numata K; Miyachi J; Misawa Y; Yamada K; Omura S
    J Antibiot (Tokyo); 1990 Mar; 43(3):295-305. PubMed ID: 2139023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal and molecular structure of (14R)-14-hydroxy-6-O-methylerythromycin A.
    Adachi T; Morimoto S; Watanabe Y; Kamiya N; Iwasaki H
    J Antibiot (Tokyo); 1989 Jun; 42(6):1012-4. PubMed ID: 2737946
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents.
    King A; Phillips I
    J Hosp Infect; 1991 Sep; 19 Suppl A():3-9. PubMed ID: 1684981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of clarithromycin by rat lung cells.
    Kohno Y; Yoshida H; Suwa T; Suga T
    J Antimicrob Chemother; 1990 Oct; 26(4):503-13. PubMed ID: 2147673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives.
    Ku YY; Riley D; Grieme T; Nilius A
    J Antibiot (Tokyo); 1999 Oct; 52(10):908-12. PubMed ID: 10604761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A.
    Morimoto S; Misawa Y; Adachi T; Nagate T; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1990 Mar; 43(3):286-94. PubMed ID: 2324013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives].
    Chen SX; Xu XD; Yu LX
    Yao Xue Xue Bao; 2001 Aug; 36(8):581-4. PubMed ID: 12579933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of erythromycins. IV. Synthesis and biological properties of 6-O-methylerythromycin B.
    Morimoto S; Adachi T; Misawa Y; Nagate T; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1990 May; 43(5):544-9. PubMed ID: 2358406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite.
    Logan MN; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1991 Feb; 27(2):161-70. PubMed ID: 1829073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin.
    Fernandes PB; Ramer N; Rode RA; Freiberg L
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):73-6. PubMed ID: 2967754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives.
    Watanabe Y; Adachi T; Asaka T; Kashimura M; Matsunaga T; Morimoto S
    J Antibiot (Tokyo); 1993 Jul; 46(7):1163-7. PubMed ID: 8360112
    [No Abstract]   [Full Text] [Related]  

  • 15. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
    Vallée E; Azoulay-Dupuis E; Swanson R; Bergogne-Bérézin E; Pocidalo JJ
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():31-41. PubMed ID: 1827100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activity.
    Griesgraber G; Or YS; Chu DT; Nilius AM; Johnson PM; Flamm RK; Henry RF; Plattner JJ
    J Antibiot (Tokyo); 1996 May; 49(5):465-77. PubMed ID: 8682724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin.
    Watanabe Y; Morimoto S; Adachi T; Kashimura M; Asaka T
    J Antibiot (Tokyo); 1993 Apr; 46(4):647-60. PubMed ID: 8501007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A.
    Morimoto S; Takahashi Y; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1984 Feb; 37(2):187-9. PubMed ID: 6706855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research and development of clarithromycin].
    Omura S; Morimoto S; Nagate T; Adachi T; Kohno Y
    Yakugaku Zasshi; 1992 Sep; 112(9):593-614. PubMed ID: 1469609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A.
    Morimoto S; Misawa Y; Asaka T; Kondoh H; Watanabe Y
    J Antibiot (Tokyo); 1990 May; 43(5):570-3. PubMed ID: 2141599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.